Minoxidil and its use in hair disorders: a review.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing pharmacology, mechanisms, efficacy, and adverse events of topical minoxidil without systematic review methodology.
PubMed 31496654 · doi:10.2147/DDDT.S214907
What was done
The authors conducted a narrative review summarizing the pharmacology, proposed mechanisms of action, clinical efficacy, and adverse event profile of topical minoxidil in androgenetic alopecia and other hair loss disorders.
What was found
The abstract provides no numerical data, effect sizes, or specific trial findings. It notes descriptively that topical minoxidil is the mainstay treatment for androgenetic alopecia and an off-label option for other hair disorders, while its precise mechanism of action remains incompletely understood.
Why it matters
This paper compiles current clinical and pharmacological concepts surrounding one of the most widely prescribed topical therapies for hair loss.
Limits
The abstract describes a narrative overview rather than a systematic review or meta-analysis. It does not report search methodology, study inclusion criteria, sample sizes, or quantitative outcome data.
Cited by
- supports Minoxidil acts as a hair growth stimulant but does not attenuate or prevent hair follicle miniaturization caused by DHT.